Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain.

@article{SnchezCovisa2014ComparativeCA,
  title={Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain.},
  author={Joaqu{\'i}n S{\'a}nchez-Covisa and Margarita Capel and Stefan A. Baeten and Bram G Verheggen},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2014},
  volume={17 7},
  pages={
          A349-50
        }
}
BETA

Topics from this paper.

Similar Papers

Loading similar papers…